| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Neuropharmacology and Neuroimmunology, Instituto Nacional De Neurologia Y Neurocirugia, Mexico.
Treatment with praziquantel for neurocysticercosis frequently induces adverse reactions due to acute destruction of parasites; these reactions are suppressed by dexamethasone therapy. However, there is controversy about the most appropriate regimen with praziquantel and dexamethasone. We studied plasma levels of praziquantel in eight patients given the drug alone or with dexamethasone. Plasma levels of praziquantel were 50% lower in the same patient when dexamethasone was given simultaneously. Dexamethasone should not be added to praziquantel therapy as preventive treatment, but should be reserved for transient therapy of adverse reactions.
Address correspondence and reprint requests to Dr. Sotelo, Research Division, Instituto Nacional De Neurologia Y Nemirugia, Insurgentes Sur 3877, 14410 Mexico 22, D.F.
Supported in part by Subsecretaria de Regulacion Sanitaria Y Desarrollo, Secretaria de Salud.
Received August 27, 1986. Accepted for publication in final form December 30, 1986.
This article has been cited by other articles:
|
|
 |
|
  L. GRANDIERE-PEREZ, S. ANSART, L. PARIS, A. FAUSSART, S. JAUREGUIBERRY, J.-P. GRIVOIS, E. KLEMENT, F. BRICAIRE, M. DANIS, and E. CAUMES Efficacy of praziquantel during the incubation and invasive phase of schistosoma haematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg, May 1, 2006; 74(5): 814 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. GARCIA, O. H. DEL BRUTTO, T. E. NASH, A. C. WHITE JR., V. C. W. TSANG, and R. H. GILMAN NEW CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF NEUROCYSTICERCOSIS (TAENIA SOLIUM) Am J Trop Med Hyg, January 1, 2005; 72(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Singhi and S. Singhi Topical Review: Neurocysticercosis in Children J Child Neurol, July 1, 2004; 19(7): 482 - 492. [Abstract] [PDF]
|
|
|
|
 |
|
 H. H. Garcia, C. A. W. Evans, T. E. Nash, O. M. Takayanagui, A. C. White Jr., D. Botero, V. Rajshekhar, V. C. W. Tsang, P. M. Schantz, J. C. Allan, et al. Current Consensus Guidelines for Treatment of Neurocysticercosis Clin. Microbiol. Rev., October 1, 2002; 15(4): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Castro, R. Medina, J. Sotelo, and H. Jung Bioavailability of Praziquantel Increases with Concomitant Administration of Food Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2903 - 2904. [Abstract] [Full Text]
|
|
|
|
|
|
P. Singhi, M. Ray, S. Singhi, and N. Khandelwal Clinical Spectrum of 500 Children With Neurocysticercosis and Response to Albendazole Therapy J Child Neurol, April 1, 2000; 15(4): 207 - 213. [Abstract] [PDF]
|
|
|
|
 |
|
 G.C.Y. Fong, R.T.F. Cheung, and J. H. Heo Caution With Praziquantel in Neurocysticercosis Stroke, August 1, 1997; 28 (8): 1648 - 1649. [Full Text]
|
|
|
|
 |
|
 J F Doherty, A H Moody, and S G Wright Lesson of the Week: Katayama fever: an acute manifestation of schistosomiasis BMJ, October 26, 1996; 313(7064): 1071 - 1072. [Full Text]
|
|
|
|
 |
|
 L. X. Liu and P. F. Weller Antiparasitic Drugs N. Engl. J. Med., May 2, 1996; 334(18): 1178 - 1184. [Full Text] [PDF]
|
|
|
|
|
|
T. Corona, R. Lugo, R. Medina, and J. Sotelo Single-Day Praziquantel Therapy for Neurocysticercosis N. Engl. J. Med., January 11, 1996; 334(2): 125 - 125. [Full Text]
|
|
|
|
|
|
J. H. Maguire and M. R. Tierney Case 8-1993- A 62-Year-Old Cape Verdean Woman with Blurred Vision, Diplopia, a Suprasellar Mass, and Lymphocytic Meningitis N. Engl. J. Med., February 25, 1993; 328(8): 566 - 573. [Full Text]
|
|
|
|
 |
|
 B.O. Dick, A.J. Janik, and V. R. Dharnidharka Letters to the Editor The Journal of the Royal Society for the Promotion of Health, February 1, 1993; 113(1): 50 - 51.
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
